NRX Pharmaceuticals, Inc. (NRXP) Stock Leaping Forward in Aftermarket, Here’s the Cause
NRX Pharmaceuticals, Inc. (NRXP), a clinical-stage small molecule pharmaceutical company, has soared by 6.85% in aftermarket trading session. Consequently, NRXP is trading at $4.99 at the time of the writing. The rise could be attributed to announcements regarding the company’s COVID-19 vaccine. On Friday, the stock closed the day at $4.67 after sliding 7.34% during […]
